Stockscreener 앱 받기
5.55
0.36%
-0.02
시간 외 거래:
5.54
-0.010
-0.18%
전일 마감가:
$5.57
열려 있는:
$5.63
하루 거래량:
2.90M
Relative Volume:
0.83
시가총액:
$1.34B
수익:
$386.15M
순이익/손실:
$-56.39M
주가수익비율:
-24.13
EPS:
-0.23
순현금흐름:
$-55.19M
1주 성능:
-4.80%
1개월 성능:
+8.82%
6개월 성능:
+32.78%
1년 성능:
+12.80%
1일 변동 폭
$5.50
$5.80
1주일 범위
$5.4001
$5.985
52주 변동 폭
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
ARDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.55 | 1.35B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 재개 | Raymond James | Strong Buy |
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-05-02 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 재개 | Ladenburg Thalmann | Buy |
| 2025-03-04 | 개시 | BTIG Research | Buy |
| 2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-18 | 개시 | Raymond James | Strong Buy |
| 2023-09-07 | 개시 | H.C. Wainwright | Buy |
| 2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-23 | 개시 | Wedbush | Outperform |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 재개 | Citigroup | Buy |
| 2020-02-18 | 재개 | Jefferies | Buy |
| 2020-02-12 | 개시 | Citigroup | Buy |
| 2020-02-10 | 개시 | Cowen | Outperform |
| 2019-04-08 | 개시 | Piper Jaffray | Overweight |
| 2018-08-24 | 개시 | Jefferies | Buy |
| 2018-03-19 | 재개 | Leerink Partners | Outperform |
| 2017-11-29 | 재확인 | Citigroup | Buy |
| 2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
| 2017-10-17 | 재개 | Leerink Partners | Outperform |
| 2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
| 2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
| 2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
How Ardelyx Inc. stock reacts to job market dataWeekly Loss Report & Consistent Return Strategy Ideas - newser.com
Will Ardelyx Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
How Ardelyx Inc. stock valuations compare to rivalsDollar Strength & Long-Term Capital Growth Strategies - newser.com
Combining machine learning predictions for Ardelyx Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
What momentum indicators show for Ardelyx Inc. stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Will Ardelyx Inc. stock deliver shareholder valueQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
Why institutional investors increase stakes in Ardelyx Inc. (41X) stockPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Is Ardelyx Inc. forming a bottoming baseWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
What high frequency data says about Ardelyx Inc.Portfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
Why Ardelyx Inc. stock is recommended by analystsPortfolio Update Summary & Proven Capital Preservation Methods - newser.com
ARDX: IBSRELA and XPHOZAH drive growth, with profitability and new pipeline assets expected by 2026 - TradingView
Ardelyx at Jefferies London Healthcare: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Ardelyx (ARDX): Evaluating Valuation After Upward Guidance Following Strong IBSRELA Sales Growth - simplywall.st
Applying big data sentiment scoring on Ardelyx Inc.Trade Risk Summary & Technical Pattern Based Signals - newser.com
Ardelyx Shares Surge After Regulatory Wins But Is the Stock Fully Priced in 2025? - Yahoo Finance
News impact scoring models applied to Ardelyx Inc.Swing Trade & Weekly Top Performers Watchlists - newser.com
Will Ardelyx Inc. (41X) stock keep high P E multiplesJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Can Ardelyx’s (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? - Yahoo Finance
A Look at Ardelyx (ARDX) Valuation Following Real-World XPHOZAH Study Results at Kidney Week - Yahoo Finance
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
0.43%
자본화:
|
볼륨(24시간):